Naveris is a commercial stage precision oncology company based near Boston, MA, dedicated to transforming cancer detection and improving patient outcomes. With a mission to ensure that no one succumbs to cancer, Naveris has developed innovative diagnostics, including their flagship test, NavDx, a breakthrough blood-based DNA test for HPV-induced cancers. Trusted by tens of thousands of patients and physicians across the U.S., Naveris is committed to delivering high-quality healthcare solutions and fostering a diverse and inclusive work environment.